Work

Distinct late recurrence patterns and immune landscape of HER2-positive invasive lobular carcinoma (ILC): Analysis of NCCTG N9831 (Alliance) trial and real-world cohort.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.564

Authors: Thiti Susiriwatananont, Sachin Kumar Deshmukh, Panuch Eiamprapaporn, Zhuo Li, Sharon Wu, Keith L. Knutson, Aziza Nassar, Yi Liu, Edith A. Perez, Dario Trapani, Maryam B. Lustberg, George W. Sledge, E. Aubrey Thompson, Saranya Chumsri

Institutions: Mayo Clinic in Florida, Caris Life Sciences (United States), Dana-Farber Cancer Institute, Yale Cancer Center, Mayo Clinic Comprehensive Cancer Center (Florida)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162521720

Cites:

Cited by:

Related to: